These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18310980)

  • 21. [Two cases of thymic hyperplasia with Basedow's disease].
    Nomori H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Oct; 28(10):1372-5. PubMed ID: 1703252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hyperthyroidism].
    Kolyvanos NU; Furrer J; Käser L; Vetter W
    Praxis (Bern 1994); 2007 Oct; 96(40):1505-11; quiz 1512-3. PubMed ID: 17966822
    [No Abstract]   [Full Text] [Related]  

  • 23. Thymic hyperplasia in thyrotoxicosis.
    Nicholson RL
    J Can Assoc Radiol; 1978 Dec; 29(4):264-5. PubMed ID: 721886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of thymic enlargement with hyperthyroidism].
    Ohno K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jul; 33(7):785-8. PubMed ID: 7564009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lambert-Eaton myasthenic syndrome and follicular thymic hyperplasia in systemic lupus erythematosus.
    Pasqualoni E; Aubart F; Brihaye B; Sacré K; Maisonobe T; Laissy JP; Lidove O; Papo T
    Lupus; 2011 Jun; 20(7):745-8. PubMed ID: 21427136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotoxic myopathy: research status, diagnosis, and treatment.
    Cui H; Zhang X
    Endokrynol Pol; 2022; 73(1):157-162. PubMed ID: 35119093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thyrotoxic hypokalemic periodic paralysis: a rare complication of a common disease].
    Foppiani L; Cuttica CM; Marugo A; Del Monte P
    Recenti Prog Med; 2012 Sep; 103(9):333-6. PubMed ID: 23023021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A case of thyrotoxic myopathy with generalized body muscular atrophy including the tongue muscle, lacking physical manifestations of Basedow disease].
    Kitahara S; Tonouchi T; Otsu Y; Kawachi I; Oyake M; Fujita N
    Rinsho Shinkeigaku; 2020 Oct; 60(10):677-681. PubMed ID: 32893239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to control of hyperthyroidism in patients with myasthenia gravis and thyrotoxicosis.
    Teoh R; Chow CC; Kay R; Cockram CS; McGuire L
    Br J Clin Pract; 1990 Dec; 44(12):742-4. PubMed ID: 2102222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thyrotoxic neuromyopathies].
    Sidibe EH; Diagne PM; Ly AB; Ndiaye IP; Sow AM
    Rev Neurol (Paris); 1998 May; 154(4):330-3. PubMed ID: 9773061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis.
    Santos E; Moreira I; Coutinho E; Gonçalves G; Lopes C; Lopes Lima J; Leite MI
    Neuromuscul Disord; 2015 Dec; 25(12):928-31. PubMed ID: 26363966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Periodic Problem.
    Kratka A; Yozamp N; Vaidya A; Marqusee E
    N Engl J Med; 2021 Jul; 385(5):e17. PubMed ID: 34320291
    [No Abstract]   [Full Text] [Related]  

  • 33. Elevation of serum creatine kinase during treatment with antithyroid drugs in patients with hyperthyroidism due to Graves disease. A novel side effect of antithyroid drugs.
    Suzuki S; Ichikawa K; Nagai M; Mikoshiba M; Mori J; Kaneko A; Sekine R; Asanuma N; Hara M; Nishii Y; Yamauchi K; Aizawa T; Hashizume K
    Arch Intern Med; 1997 Mar; 157(6):693-6. PubMed ID: 9080924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic imaging and therapy in a case of myasthenia gravis associated with thymic hyperplasia.
    Foschi R; Rinaldi P; Meduri A; Campioni P; Pirronti T
    Rays; 2003; 28(4):369-78. PubMed ID: 15152539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthyroidism presenting with hyperglycemia in an adolescent female.
    Wintergerst KA; Rogers ES; Foster MB
    J Pediatr Endocrinol Metab; 2011; 24(5-6):385-7. PubMed ID: 21823542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thymic hyperplasia in Graves' disease.
    Van Herle AJ; Chopra IJ
    J Clin Endocrinol Metab; 1971 Feb; 32(2):140-6. PubMed ID: 4099281
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyrotoxic hypokalemic periodic paralysis in a Turkish male with graves' disease: a rare case report and review of the literature.
    Erem C
    Endocrine; 2005 Jun; 27(1):63-5. PubMed ID: 16077173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Proximal muscle weakness, depressed tendon reflexes and autonomic dysfunction: the Lambert-Eaton myasthenic syndrome].
    Wirtz PW; Kuks JB; Wintzen AR; Verschuuren JJ
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):57-61. PubMed ID: 11225256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic hyperplasia in patients with Graves' disease.
    Dalla Costa M; Mangano FA; Betterle C
    J Endocrinol Invest; 2014 Dec; 37(12):1175-9. PubMed ID: 25149085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic hyperplasia and its spontaneous resolution with treatment of Graves' hyperthyroidism.
    Shanmugasundaram M; Varadhan L; Katreddy MV; Nayak AU
    BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27190120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.